Skip to main navigation Skip to search Skip to main content

Is glucagonoma of the pancreas a curable disease?

  • Quyen D. Chu
  • , Mazin F. Al-kasspooles
  • , Judy L. Smith
  • , Hector R. Nava
  • , Harold O. Douglass
  • , Deborah Driscoll
  • , John F. Gibbs
  • Roswell Park Cancer Institute

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

Background. Glucagonomas are rare neuroendocrine tumors of the pancreas. Because of its rarity, its natural history is not well understood. Aim. We evaluated the natural history of glucagonomas treated at a tertiary care cancer center. Methods. A retrospective analysis of 12 patients during 1970 to 2000 was performed. Six patients (50%) had a tumor located in the head of the pancreas. Results. Abdominal pain (83%) and weight loss (75%) were the most common symptoms. Median tumor size was 6 cm (range 0.04-10). Seven patients (58%) had liver metastases. Five patients (42%) underwent curative resection. Overall median survival was 66 mo, and 5-yr overall survival was 66%. Five-yr overall survival was 83% for patients who had resection versus 50% for the non-resected patients (p = 0.04). Patients who were disease-free had a complete resection of the primary tumor and no liver involvement. Conclusions. Glucagonomas generally present with liver metastases at the time of diagnosis. Cure is only possible if the disease is localized and completely resected.

Original languageEnglish
Pages (from-to)155-162
Number of pages8
JournalInternational Journal of Pancreatology
Volume29
Issue number3
DOIs
StatePublished - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Glucagonomas
  • Neuroendocrine tumor
  • Pancreas tumor
  • Pancreatic resection

Fingerprint

Dive into the research topics of 'Is glucagonoma of the pancreas a curable disease?'. Together they form a unique fingerprint.

Cite this